H.C. Wainwright Highlight Curative Potential of Legend Biotech Corporation (LEGN)'s Carvykti Despite Sales Miss [Yahoo! Finance]
Legend Biotech Corporation - American Depositary Shares (LEGN)
Company Research
Source: Yahoo! Finance
TheFly reported on January 22 that H.C. Wainwright lowered LEGN's price target to $50 from $60 but kept a Buy rating, noting Q4 Carvykti sales of $555M missed the $582M consensus. They view the recent pullback as a buying opportunity and highlighted Carvykti's curative potential. Similarly, a day earlier on January 21, TD Cowen downgraded Legend Biotech Corporation (NASDAQ:LEGN) from Buy to Hold and cut the price target to $21 from $62. The firm said Carvykti's Q4 sales of $555 million versus the $582 million consensus reflected holiday seasonality but also indicated sluggish demand, which is influenced by toxicity concerns and growing competition. These factors have slowed adoption in the community and limited uptake even in academic centers. Legend Biotech Corporation (NASDAQ:LEGN) is a global biotechnology company focused on developing and commercializing advanced cell therapies, especially CAR-T treatments for cancer, like CARVYKTI for multiple myeloma. It collaborates with p
Show less
Read more
Impact Snapshot
Event Time:
LEGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LEGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LEGN alerts
High impacting Legend Biotech Corporation - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
LEGN
News
- Legend Biotech (LEGN) Valuation Check After Recent Share Price Pullback [Yahoo! Finance]Yahoo! Finance
- GenScript Biotech Global Forum, "Scripting Possibilities", Convened AI and Biopharma Leaders in San FranciscoPR Newswire
- Legend Biotech (LEGN) Advances Cell Therapy Innovation and Expands Oncology Pipeline [Yahoo! Finance]Yahoo! Finance
- Legend Biotech: Carvykti Driving Growth Amid FDA Regulatory Tailwinds [Seeking Alpha]Seeking Alpha
- Legend Biotech (NASDAQ:LEGN) had its price target lowered by analysts at HC Wainwright from $60.00 to $50.00. They now have a "buy" rating on the stock.MarketBeat
LEGN
Sec Filings
- 1/23/26 - Form 6-K
- 1/21/26 - Form 6-K
- 1/14/26 - Form 6-K
- LEGN's page on the SEC website